术后或新/辅助化学免疫疗法与可切除非小细胞肺癌的化疗:系统性审查和网络元分析
Qiong Zhang1, Jia Duan2, Yuanmei Zhang1
1Department of Geriatrics, Neijiang First People's Hospital, , Sichuan Province, Neijiang, China.
Systematic reviews
|January 25, 2025
概括
术后免疫疗法与化疗相结合,显著改善非小细胞肺癌 (NSCLC) 患者的整体存活率. 虽然有效,但免疫治疗的谨慎管理是有效的.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床试验 临床试验
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因.
- 切除性NSCLC的手术切除是主要的,但术后复发是常见的.
- 术后免疫疗法与化疗相结合是一种新兴的治疗策略.
研究的目的:
- 为了比较新辅助剂,辅助剂和术后免疫疗法加化疗与单独化疗在可切除的NSCLC中的疗效和安全性.
- 评估对无事件生存 (EFS) 和整体生存 (OS) 的影响.
- 评估不良事件 (AE) 的发生率和严重程度.
主要方法:
- 按照PRISMA指南进行系统审查和频率网络元分析.
- 在PubMed,Embase和Cochrane数据库中搜索相关的随机对照试验 (RCT).
- 包括13个RCT,其中6704名患者患有可切除的NSCLC.
主要成果:
- 与化学疗法的新辅助和术后免疫疗法相比,单独使用化学疗法显著改善了无进展生存期 (PFS).
- 与辅助免疫疗法和标准化疗相比,外科免疫疗法显示出更高的整体存活率 (OS).
- 化疗的严重副作用较少,但免疫疗法组合通常耐受良好.
结论:
- 新辅助和术后免疫疗法与化疗相结合,可切除的NSCLC的存活率提高.
- 长期使用免疫疗法需要仔细管理潜在的不良影响.
- 需要进一步的研究来优化治疗策略,并澄清免疫治疗在特定患者亚组中的作用.
更多相关视频
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.2K
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.5K
相关概念视频
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K